Hamilton Herald Masthead

Editorial


Front Page - Friday, March 26, 2021

Colorectal cancer screenings should not be ignored




Declining rates of colorectal cancer diagnoses underscores the importance of partnering with a primary care physician who can help identify lifestyle, genetic or other risk factors that determine when screening should begin and with what frequency, says Dr. Samuel Abbas of Parkridge Medical Group. - Photograph provided

The American Cancer Society forecasts 104,270 new cases of colon cancer and 45,230 new cases of rectal cancer in 2021, making it the second most common cause of cancer death in the U.S.

But despite the high mortality rate of the disease, increased screening and greater awareness of preventive changes are driving down the number of annual colorectal cancer diagnoses, says Dr. Samuel Abbas, internal medicine physician with Parkridge Medical Group East Ridge.

“The success we have seen in decreasing rates of colorectal cancer diagnoses each year underscores the importance of knowing your risk for the disease and partnering with a primary care physician who can help you identify lifestyle, genetic or other risk factors that determine when screening should begin and with what frequency,” Abbas says.

Knowing one’s risk for colorectal cancer and following established screening guidelines is critical for detecting the disease in its earliest, most treatable stages, Abbas says. Unfortunately, the COVID-19 pandemic has led to significant decreases in cancer screening.

To reassure the public, Parkridge Health is taking every precaution at its facilities to create a safe environment for screenings.

“Since the onset of the pandemic, Parkridge Health has instituted protocols to prevent transmission of respiratory illness,” Abbas reports. “From universal masking, social distancing and handwashing guidelines to virtual appointments and rigorous requirements for disinfecting high-touch areas, we’ve done everything in our power to increase the safety of our patients at all points on their health care journey.”

Knowing your risk

The U.S. Preventive Services Task Force recommends colorectal screening begin at age 50 for most people, but for those who are at increased risk, some guidelines recommend beginning screening at age 45.

Because colorectal cancer screening guidelines are complex, a primary care provider is a key partner in evaluating one’s level of risk and at what age a person should begin annual colorectal cancer screenings.

Those who are at average risk for colorectal cancer do not have any of the following:

• Confirmed or suspected hereditary colorectal cancer syndrome

• Family history of colorectal cancer

• Personal history of colorectal cancer or polyps

• Personal history of inflammatory bowel disease

• Personal history of radiation therapy to the abdomen or pelvic area

Those who are at increased or high risk for colorectal cancer might need to begin colorectal cancer screening before 45 years old and adhere to a personalized screening schedule. People in this category do have any of the following:

• Family history of hereditary colorectal cancer syndrome

• Family or personal history of colorectal cancer or polyps

• Personal history of inflammatory bowel disease

• Personal history of radiation therapy to the abdomen or pelvic area

Detecting colorectal cancer when the disease has not spread beyond the colon or rectum significantly increases the chances of successful treatment. According to the ACS, five-year survival rates increase by more than 70% when colon or rectal cancer is discovered in its earliest stages.

Source: Parkridge Health System